Analysts’ updated eps estimates for Thursday, September 14th:

Apple (NASDAQ:AAPL) had its price target increased by Maxim Group from $180.00 to $182.00. The firm currently has a buy rating on the stock.

Sanford C. Bernstein began coverage on shares of Aegon NV (NYSE:AEG). The firm issued a market perform rating on the stock.

Applied Genetic Technologies Corporation (NASDAQ:AGTC) had its target price reduced by Cantor Fitzgerald to $9.00. They currently have a neutral rating on the stock.

Alaska Air Group (NYSE:ALK) had its price target reduced by Cowen and Company from $103.00 to $100.00. They currently have an outperform rating on the stock.

Bed Bath & Beyond (NASDAQ:BBBY) had its target price cut by UBS AG from $33.00 to $30.00. They currently have a neutral rating on the stock.

J P Morgan Chase & Co started coverage on shares of Berkshire Hathaway (NYSE:BRK). J P Morgan Chase & Co issued an overweight rating and a $210.00 price target on the stock.

J P Morgan Chase & Co initiated coverage on shares of Berkshire Hathaway (NASDAQ:BRK-A). J P Morgan Chase & Co issued an overweight rating and a $268,450.00 target price on the stock.

LivaNova PLC (NASDAQ:LIVN) had its hold rating reissued by analysts at Needham & Company LLC. The analysts wrote, “LIVN announced that it is exploring strategic options for its low growth and low margin CRM business. This shouldn’t come as a huge surprise since management had previously hinted a potential sale of the CRM business. We think a CRM sale would increase LIVN’s revenue growth; the EPS impact hinges on price, CRM margins, and use of proceeds. We think a sale would be neutral to slightly dilutive if the proceeds were used for share repurchases and/or debt repayment though we note that there would likely be near-term hit to EPS between when the sale is announced and when LIVN is able to deploy the proceeds to offset any dilution.””

Lattice Semiconductor Corporation (NASDAQ:LSCC) had its buy rating reissued by analysts at Craig Hallum. They currently have a $6.00 price target on the stock, down from their previous price target of $8.30.

Nike (NYSE:NKE) had its neutral rating reissued by analysts at Wedbush. The firm currently has a $53.40 target price on the stock, up from their previous target price of $52.00.

Pfizer (NYSE:PFE) had its buy rating reaffirmed by analysts at BMO Capital Markets. They currently have a $37.00 price target on the stock.

Synopsys (NASDAQ:SNPS) had its average rating reaffirmed by analysts at HSBC Holdings plc.

Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.